STOCK TITAN
  1. Home
  2. Sec-filings
  3. RADX
  4. [EFFECT] Radiopharm Theranostics Ltd SEC Filing

[EFFECT] Radiopharm Theranostics Ltd SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 23, 2025 9:00 A.M.
Form: F-3
CIK: 0001949257
Company Name: Radiopharm Theranostics Ltd
File Number: 333-292178

Source: View Original Filing on SEC EDGAR

Stock RADX logo
Radiopharm Theranostics Ltd

NASDAQ:RADX

RADX Rankings

#5689 Ranked by Market Cap
N/A Ranked by Dividends
#194 Top Gainer

RADX Latest News

Dec 15, 2025
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
Nov 18, 2025
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
Nov 17, 2025
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
Nov 12, 2025
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
Oct 20, 2025
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

RADX Latest SEC Filings

Dec 17, 2025
[F-3] Radiopharm Theranostics Ltd Foreign Issuer Shelf Registration
Dec 16, 2025
[F-3] Radiopharm Theranostics Ltd Foreign Issuer Shelf Registration
Dec 15, 2025
[6-K] Radiopharm Theranostics Ltd Current Report (Foreign Issuer)
Nov 25, 2025
[6-K] Radiopharm Theranostics Ltd Current Report (Foreign Issuer)
Nov 20, 2025
[6-K] Radiopharm Theranostics Ltd Current Report (Foreign Issuer)

RADX Stock Data

38.31M
11.81M
5.41%
0.56%
Biotechnology
Healthcare
Link
Australia
Carlton